Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $51,294,396 |
Sells | 143 | $59,705,589 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 29 Aug 2023 | Purchase | 3,750,000 | 6.2 | 23,250,000 | I |
25 Sep 2023 16:30 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 21 Sep 2023 | Purchase | 2,508,691 | 2.97 | 7,450,812 | I |
23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Mar 2024 | Purchase | 505,954 | 9.79 | 4,953,290 | I |
27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 26 Mar 2024 | Purchase | 457,745 | 9.55 | 4,371,465 | I |
27 Mar 2024 19:37 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 25 Mar 2024 | Purchase | 437,600 | 9.06 | 3,964,656 | I |
31 Aug 2023 17:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
31 Aug 2023 17:18 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 29 Aug 2023 | Purchase | 500,000 | 6.2 | 3,100,000 | I |
28 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
05 Sep 2023 20:04 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 01 Sep 2023 | Sale | 100,000 | 7.7052 | 770,520 | D |
21 Aug 2024 18:51 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 20 Aug 2024 | Sale | 50,000 | 15 | 750,000 | D |
25 Sep 2023 16:30 | SPRY | ARS Pharmaceuticals Inc | RA CAPITAL MANAGEMENT, L.P. | Director | 21 Sep 2023 | Purchase | 191,309 | 3.83 | 732,713 | I |
19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9336 | 646,680 | I |
19 Sep 2024 16:29 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
19 Sep 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 17 Sep 2024 | Sale | 50,000 | 12.9305 | 646,525 | I |
12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4982 | 574,910 | I |
12 Sep 2024 16:25 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
12 Sep 2024 16:24 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 10 Sep 2024 | Sale | 50,000 | 11.4973 | 574,865 | I |
18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4031 | 570,155 | I |
18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4031 | 570,155 | I |
18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4028 | 570,140 | I |
18 Jul 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Jul 2024 | Sale | 50,000 | 11.4028 | 570,140 | I |
21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 36,216 | 14.7576 | 534,461 | I |
21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 35,944 | 14.7565 | 530,408 | I |
02 Jun 2023 19:48 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 01 Jun 2023 | Sale | 73,059 | 6.8 | 496,801 | D |
11 Jul 2024 17:03 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6177 | 480,885 | I |
11 Jul 2024 17:04 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6177 | 480,885 | I |
11 Jul 2024 17:03 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6168 | 480,840 | I |
11 Jul 2024 17:04 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Jul 2024 | Sale | 50,000 | 9.6168 | 480,840 | I |
09 May 2024 18:57 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 07 May 2024 | Sale | 50,000 | 9.3446 | 467,230 | I |
09 May 2024 18:59 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 07 May 2024 | Sale | 50,000 | 9.3446 | 467,230 | I |
09 May 2024 18:57 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 07 May 2024 | Sale | 50,000 | 9.3427 | 467,135 | I |
09 May 2024 18:59 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 07 May 2024 | Sale | 50,000 | 9.3427 | 467,135 | I |
17 Apr 2024 18:40 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Apr 2024 | Sale | 50,000 | 9.2804 | 464,020 | I |
17 Apr 2024 18:42 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Apr 2024 | Sale | 50,000 | 9.2804 | 464,020 | I |
17 Apr 2024 18:40 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 Apr 2024 | Sale | 50,000 | 9.2797 | 463,985 | I |
17 Apr 2024 18:42 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 Apr 2024 | Sale | 50,000 | 9.2797 | 463,985 | I |
10 Apr 2024 17:39 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Apr 2024 | Sale | 50,000 | 9.2777 | 463,885 | I |
10 Apr 2024 17:36 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Apr 2024 | Sale | 50,000 | 9.2777 | 463,885 | I |
10 Apr 2024 17:39 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 09 Apr 2024 | Sale | 50,000 | 9.277 | 463,850 | I |
10 Apr 2024 17:36 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 09 Apr 2024 | Sale | 50,000 | 9.277 | 463,850 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 35,401 | 12.7646 | 451,880 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 35,401 | 12.7646 | 451,880 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 35,363 | 12.7659 | 451,441 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 35,363 | 12.7659 | 451,441 | I |
15 Mar 2024 19:55 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Mar 2024 | Sale | 48,461 | 9.1413 | 442,997 | I |
15 Mar 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Mar 2024 | Sale | 48,461 | 9.1413 | 442,997 | I |
28 Feb 2024 21:08 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 28 Feb 2024 | Sale | 49,019 | 9.0212 | 442,210 | I |
28 Feb 2024 21:04 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 28 Feb 2024 | Sale | 49,019 | 9.0212 | 442,210 | I |
15 Mar 2024 19:55 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 15 Mar 2024 | Sale | 48,295 | 9.1415 | 441,489 | I |
15 Mar 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 15 Mar 2024 | Sale | 48,295 | 9.1415 | 441,489 | I |
13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Jun 2024 | Sale | 48,028 | 9.1447 | 439,202 | I |
13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Jun 2024 | Sale | 48,028 | 9.1447 | 439,202 | I |
13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 12 Jun 2024 | Sale | 47,834 | 9.1454 | 437,461 | I |
13 Jun 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 12 Jun 2024 | Sale | 47,834 | 9.1454 | 437,461 | I |
26 Mar 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 25 Mar 2024 | Sale | 47,635 | 9.1238 | 434,612 | I |
26 Mar 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 25 Mar 2024 | Sale | 47,635 | 9.1238 | 434,612 | I |
26 Mar 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 25 Mar 2024 | Sale | 47,632 | 9.1236 | 434,575 | I |
26 Mar 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 25 Mar 2024 | Sale | 47,632 | 9.1236 | 434,575 | I |
16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 May 2024 | Sale | 44,746 | 9.0581 | 405,314 | I |
16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 May 2024 | Sale | 44,746 | 9.0581 | 405,314 | I |
16 May 2024 19:51 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 16 May 2024 | Sale | 44,350 | 9.0577 | 401,709 | I |
16 May 2024 19:52 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 16 May 2024 | Sale | 44,350 | 9.0577 | 401,709 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | DORSEY BRIAN | Chief Operating Officer | 13 Aug 2024 | Sale | 30,000 | 13 | 390,000 | D |
10 May 2023 16:53 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 08 May 2023 | Sale | 57,100 | 6.16 | 351,736 | D |
03 Aug 2023 18:03 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 02 Aug 2023 | Sale | 36,281 | 7.0909 | 257,265 | D |
28 Feb 2024 21:08 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 28 Feb 2024 | Sale | 25,456 | 9.0205 | 229,626 | I |
28 Feb 2024 21:04 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 28 Feb 2024 | Sale | 25,456 | 9.0205 | 229,626 | I |
10 May 2023 16:53 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 09 May 2023 | Sale | 42,900 | 5.31 | 227,799 | D |
28 Feb 2024 21:08 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 28 Feb 2024 | Sale | 24,303 | 9.0205 | 219,225 | I |
28 Feb 2024 21:04 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 28 Feb 2024 | Sale | 24,303 | 9.0205 | 219,225 | I |
06 Jul 2023 20:55 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 06 Jul 2023 | Sale | 33,510 | 6.343 | 212,554 | D |
10 May 2023 16:53 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 09 Nov 2022 | Sale | 43,896 | 4.58 | 201,044 | D |
21 Aug 2024 18:49 | SPRY | ARS Pharmaceuticals Inc | SCOTT KATHLEEN D. | Chief Financial Officer | 20 Aug 2024 | Sale | 12,500 | 16 | 200,000 | D |
06 Jul 2023 20:55 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 05 Jul 2023 | Sale | 31,112 | 6.414 | 199,552 | D |
23 Aug 2024 18:41 | SPRY | ARS Pharmaceuticals Inc | THOMPSON PETER A. | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
02 Jun 2023 19:48 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 02 Jun 2023 | Sale | 26,941 | 6.95 | 187,240 | D |
21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,756 | 15.6129 | 183,545 | I |
07 Aug 2023 17:05 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 03 Aug 2023 | Sale | 26,107 | 7.0103 | 183,018 | D |
21 Aug 2024 18:47 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
21 Aug 2024 18:48 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 20 Aug 2024 | Sale | 11,523 | 15.6234 | 180,028 | I |
06 Jul 2023 20:55 | SPRY | ARS Pharmaceuticals Inc | SHAWVER LAURA | Director | 03 Jul 2023 | Sale | 26,520 | 6.725 | 178,347 | D |
02 Oct 2023 16:23 | SPRY | ARS Pharmaceuticals Inc | FITZPATRICK ALEXANDER A | Chief Legal Officer | 29 Sep 2023 | Purchase | 46,258 | 3.783 | 174,994 | D |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 14,637 | 11.7734 | 172,327 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 14,637 | 11.7734 | 172,327 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | LOWENTHAL RICHARD E | PRESIDENT AND CEO, 10% | 13 Aug 2024 | Sale | 14,599 | 11.7753 | 171,908 | I |
15 Aug 2024 16:30 | SPRY | ARS Pharmaceuticals Inc | TANIMOTO SARINA | CHIEF MEDICAL OFFICER, 10% | 13 Aug 2024 | Sale | 14,599 | 11.7753 | 171,908 | I |
02 Oct 2023 16:23 | SPRY | ARS Pharmaceuticals Inc | FITZPATRICK ALEXANDER A | Chief Legal Officer | 28 Sep 2023 | Purchase | 40,000 | 3.624 | 144,960 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)